MORRISVILE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, today announced that it has received the Southeast Deal of the Year Venture Capital Transaction Award from Southeast BIO (SEBIO), a nonprofit organization that fosters the growth of the life sciences industry in the U.S. Southeastern region. TearScience was recognized for having raised $44.5 million Series C financing in May, 2010. TearScience’s C round investors included Essex Woodlands Health Ventures, Investor Growth Capital, General Catalyst, De Novo Ventures, Spray Ventures and Quaker BioVentures.
